CAMP and cancer: Regarding CAMP biological actions in tumoral cells, it is noteworthy to mention that CAMP expression has been closely correlated to HER2 [14] and has been shown to transactivate EGFR [24, 25], which may explain why cancer cells exposed to the CAMP active peptide LL-37 show increased cell proliferation and invasion [8].